Evidence map›Paper›PMID 39623867›Full record

ArticleEuropean journal of immunology2025

Probing TCR Specificity Using Artificial In Vivo Diversification of CDR3 Regions.

Orlando B Giorgetti, Annette Haas-Assenbaum, Thomas Boehm

Abstract read
In one paragraph

Article in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Orlando B GiorgettiDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Annette Haas-AssenbaumDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Thomas BoehmDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Funding

Deutsche Forschungsgemeinschaft 256073931-SFB1160Max Planck Society
6 · The paper itself

Abstract

The T-cell receptor sequences expressed on cells recognizing a specific peptide in the context of a given MHC molecule can be explored for common features that might explain their antigen specificity. However, despite the development of numerous experimental and bioinformatic strategies, the specificity problem remains unresolved. To address the need for additional experimental paradigms, we report here on an in vivo experimental strategy designed to artificially diversify a transgenic TCR by CRISPR/Cas9-mediated mutagenesis of Tcra and Tcrb chain genes. In this system, an initially monoclonal repertoire of known specificity is converted into an oligoclonal pool of TCRs of altered antigen reactivity. Tracking the fate of individual clonotypes during the intrathymic differentiation process illuminates the strong selective pressures that shape the repertoire of naïve T cells. Sequence analyses of the artificially diversified repertoires identify key amino acid residues in the CDR3 regions required for antigen recognition, indicating that artificial diversification of well-characterized TCR transgene sequences helps to reduce the complexities of learning the rules of antigen recognition.

Indexed as

Complementarity Determining RegionsReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaT-LymphocytesAnimalsCRISPR-Cas SystemsMiceMice, TransgenicComplementarity Determining RegionsReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaRepertoireT cellsTCR

Identifiers

PMID39623867
PMCPMC11739678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.